HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.

Saved in:
Bibliographic Details
Title: HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.
Authors: Shen X; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA. sxshen@duke.edu., Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Soweto, South Africa., Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., McMillan AS; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Spreng RL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Yates NL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Juliana McElrath M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Allen M; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Pensiero M; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Mehra VL; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Der Meeren OV; GSK Vaccines, Rixensart, Belgium., Barnett SW; GSK Vaccines (formerly Novartis Vaccines), Cambridge, Massachusetts, USA.; Bill & Melinda Gates Foundation, Seattle, Washington, USA., Phogat S; Sanofi Pasteur, Swiftwater, Pennsylvania, USA., Gray GE; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Soweto, South Africa.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; South African Medical Research Council, Cape Town, South Africa., Bekker LG; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Tomaras GD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA. gdt@duke.edu.; Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA. gdt@duke.edu.; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA. gdt@duke.edu.; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA. gdt@duke.edu.
Source: Scientific reports [Sci Rep] 2020 Feb 07; Vol. 10 (1), pp. 2093. Date of Electronic Publication: 2020 Feb 07.
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32034163
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shen+X%22">Shen X</searchLink>; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA. sxshen@duke.edu.<br /><searchLink fieldCode="AU" term="%22Laher+F%22">Laher F</searchLink>; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Soweto, South Africa.<br /><searchLink fieldCode="AU" term="%22Moodie+Z%22">Moodie Z</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22McMillan+AS%22">McMillan AS</searchLink>; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Spreng+RL%22">Spreng RL</searchLink>; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Gilbert+PB%22">Gilbert PB</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Huang+Y%22">Huang Y</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Yates+NL%22">Yates NL</searchLink>; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Grunenberg+N%22">Grunenberg N</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Juliana+McElrath+M%22">Juliana McElrath M</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Allen+M%22">Allen M</searchLink>; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Pensiero+M%22">Pensiero M</searchLink>; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Mehra+VL%22">Mehra VL</searchLink>; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Der+Meeren+OV%22">Der Meeren OV</searchLink>; GSK Vaccines, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Barnett+SW%22">Barnett SW</searchLink>; GSK Vaccines (formerly Novartis Vaccines), Cambridge, Massachusetts, USA.; Bill & Melinda Gates Foundation, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Phogat+S%22">Phogat S</searchLink>; Sanofi Pasteur, Swiftwater, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Gray+GE%22">Gray GE</searchLink>; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Soweto, South Africa.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; South African Medical Research Council, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Bekker+LG%22">Bekker LG</searchLink>; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Corey+L%22">Corey L</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Tomaras+GD%22">Tomaras GD</searchLink>; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA. gdt@duke.edu.; Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA. gdt@duke.edu.; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA. gdt@duke.edu.; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA. gdt@duke.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2020 Feb 07; Vol. 10 (1), pp. 2093. <i>Date of Electronic Publication: </i>2020 Feb 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32034163
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41598-020-57491-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2093
    Titles:
      – TitleFull: HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shen X
      – PersonEntity:
          Name:
            NameFull: Laher F
      – PersonEntity:
          Name:
            NameFull: Moodie Z
      – PersonEntity:
          Name:
            NameFull: McMillan AS
      – PersonEntity:
          Name:
            NameFull: Spreng RL
      – PersonEntity:
          Name:
            NameFull: Gilbert PB
      – PersonEntity:
          Name:
            NameFull: Huang Y
      – PersonEntity:
          Name:
            NameFull: Yates NL
      – PersonEntity:
          Name:
            NameFull: Grunenberg N
      – PersonEntity:
          Name:
            NameFull: Juliana McElrath M
      – PersonEntity:
          Name:
            NameFull: Allen M
      – PersonEntity:
          Name:
            NameFull: Pensiero M
      – PersonEntity:
          Name:
            NameFull: Mehra VL
      – PersonEntity:
          Name:
            NameFull: Der Meeren OV
      – PersonEntity:
          Name:
            NameFull: Barnett SW
      – PersonEntity:
          Name:
            NameFull: Phogat S
      – PersonEntity:
          Name:
            NameFull: Gray GE
      – PersonEntity:
          Name:
            NameFull: Bekker LG
      – PersonEntity:
          Name:
            NameFull: Corey L
      – PersonEntity:
          Name:
            NameFull: Tomaras GD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 02
              Text: 2020 Feb 07
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2045-2322
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Scientific reports
              Type: main
ResultId 1